ARTICLE | Clinical News
Peru-15: Began Phase IIb testing
October 23, 2000 7:00 AM UTC
Avant Immunotherapeutics Inc. (AVAN), Needham, Mass. Product: Peru-15 Business: Infectious diseases Therapeutic category: Immune stimulation Target: Immune cells Description: Cholera vaccine Indicati...